Company Says Anti-Inflammatory Drug May Shorten Recovery Time For Patients Hospitalized With COVID-19
September 15, 2020
The AP (9/14, Marchione) reports Eli Lilly announced that the addition of the anti-inflammatory rheumatoid arthritis drug Olumiant (baricitinib) to remdesivir shortened recovery time for patients hospitalized with COVID-19. The company shared the results...